Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
December-2014 Volume 34 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2014 Volume 34 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Oxidized S100A4 inhibits the activation of protein phosphatase 5 through S100A1 in MKN‑45 gastric carcinoma cells

  • Authors:
    • Mitsumasa Tsuchiya
    • Fuminori Yamaguchi
    • Seiko Shimamoto
    • Tomohito Fujimoto
    • Hiroshi Tokumitsu
    • Masaaki Tokuda
    • Ryoji Kobayashi
  • View Affiliations / Copyright

    Affiliations: Department of Signal Transduction Sciences, Kagawa University Faculty of Medicine, Kagawa 761‑0793, Japan, Department of Cell Physiology, Kagawa University Faculty of Medicine, Kagawa 761‑0793, Japan
  • Pages: 1713-1719
    |
    Published online on: September 29, 2014
       https://doi.org/10.3892/ijmm.2014.1947
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

S100 proteins bind to numerous target proteins, as well as other S100 proteins and activate signaling cascades. S100 proteins can be modified by various post‑translational modifications, such as phosphorylation, methylation and acetylation. In addition, oxidation is important for modulating their activities. Previous studies have shown that S100A1 interacts with S100A4 in vitro and in vivo. Due to this potential cross‑talk among the S100 proteins, the aim of the present study was to examine whether S100A4 modulates the activity of S100A1. S100A4 was readily oxidized and formed disulfide‑linked dimers and oligomers. Although non‑oxidized S100A4 bound to protein phosphatase 5 (PP5), the Cu‑oxidized S100A4 failed to bind PP5. Instead, the Cu‑oxidized S100A4 directly interacted with S100A1 and prevented PP5 activation. Hydrogen peroxide induced S100A4 oxidation in MKN‑45 gastric adenocarcinoma cells and decreased S100A1‑PP5 interaction, resulted in the inhibition of PP5 activation by S100A1. These data indicate that oxidized S100A4 regulates PP5 activity in a unique manner under oxidative stress conditions.

Introduction

S100A4 protein is a member of the EF-hand calcium ion-binding protein family, of which >25 members have been found in humans (1). They are 25–65% homologous at the amino acid level, while the sequence of the linker (hinge) region and the C-terminal extension are the most variable among the S100 proteins. Each S100 monomer contains two EF-hand Ca2+-binding sites. Ca2+-binding causes a conformational change and exposure of a hydrophobic surface allowing interaction with target proteins (2). They do not possess enzymatic activity, but rather regulate the activity of target proteins. Several proteins have been identified as S100A4 targets, including liprin β1 (3), methionine aminopeptidase (4), the p53 tumor suppressor protein (5) and the heavy chain of non-muscle myosin II (6). In addition, S100A4 is capable of forming heterodimers with S100A1 (7,8), which is likely to increase its functional potential. Previous studies have shown that S100A4 interacts with S100A1 via heterodimer formation and that S100A1 can antagonize function of S100A4 (9,10). It has been a general observation that two-hybrid screenings utilizing S100 proteins have primarily detected other S100 family members as targets (11–13).

We have previously demonstrated that S100A1, A2, A6 and S100B interact with the tetratricopeptide repeat (TPR) domain of PP5 in a Ca2+-dependent manner and significantly activate its phosphatase activity (14). PP5 is a member of the phosphoprotein phosphatase (PPP) family of a serine/threonine phosphatase (15). PP5 contains a C-terminal catalytic domain and N-terminal three TPR motifs that are unique in the PPP family (16,17). The TPR motif consists of 34 amino acid sequences, and between 3 and 16 copies of the motif are arranged in the proteins as tandem arrays (18,19). This motif can act as an interaction scaffold for protein complex formation. PP5 is a negative regulator of the apoptosis stimulating kinase 1 (ASK1) and modulates the apoptosis under oxidative stress conditions (20). Gastric epithelium is constantly exposed to reactive oxygen species (ROS) and activation of ASK1 by Helicobacter pylori under oxidative stress was reported previously (21).

The purpose of the present study was to investigate whether S100A4 affects S100A1 function (i.e., PP5 activation) under oxidative conditions. The oxidized form of S100A4, but not the native S100A4 dimer, was found to inhibit the activation of PP5 by S100A1 in vitro and in MKN-45 cells.

Materials and methods

Materials

Nickel-nitrilotriacetic acid-agarose was purchased from Qiagen (Hilden, Germany). Rabbit anti-S100A1 antibody (NB100-91955) was obtained from Novus Biologicals (Littleton, CO, USA). Sheep anti-S100A4 antibody (AF4138) was obtained from R&D Systems (Minneapolis, MN, USA). Mouse anti-FLAG-horseradish peroxidase (HRP) antibody (A8592) and other chemicals were purchased from Sigma (St. Louis, MO, USA). Goat-anti-rabbit IgG- HRP-linked antibody (7074) was obtained from Cell Signaling (Beverly, MA, USA) and Donkey-anti-sheep IgG-HRP-conjugated antibody (HAF016) was purchased from R&D Systems.

Plasmids and recombinant proteins

Human PP5 [GenBank: NM_006247] was cloned to pET16a and pME18S-FLAG vector, and rat S100A1 [Genbank: NM_001007636] and rat S100A4 [Genbank: NM_012618] were cloned to pET11a plasmids as previously reported (14). Histidine-tagged PP5 (His-PP5) protein was expressed and purified according to the manufacturer’s instructions. S100A1 and S100A4 proteins were expressed and purified as previously described (22,23). Purified recombinant S100A4 proteins were diluted (0.5 mg/ml) and maintained at −30°C in a freezer for 3 months (air-oxidized). Cu-oxidized S100A4 protein was prepared in accordance with a previous study (24). Briefly, S100A4 (10 μM) was incubated with 80 μM of CuCl2 in 20 mM Tris-HCl buffer (pH 7.6) for 2 h at 37°C. Subsequent to stopping the reaction with the copper chelator diethylenetriamine-N,N,N′,N′,N′-pentaacetic acid, the product solution was desalted using centriprep-3 (Amicon, Inc., Beverly, MA, USA), dialyzed against 20 mM Tris-HCl buffer (pH 7.6). For Tricine SDS-PAGE analysis, samples were treated with (reducing conditions) or without (non-reducing conditions) 10 mM dithiothreitol (DTT) prior to electrophoresis.

Cell culture and H2O2 treatment

MKN-45 cells were purchased from the Japanese Collection of Research Bioresources (Osaka, Japan) and maintained in RPMI-1640 (Sigma) supplemented with 10% fetal bovine serum and 1% penicillin and streptomycin in a humidified 5% CO2 incubator. For the oxidative stress experiment, 5.5×105 cells were plated on a 10-cm dish and cultured for 3 days in standard medium. Medium was aspirated and washed with phosphate-buffered saline (PBS) and cells were exposed to the indicated concentrations of H2O2 ranging from 0 to 2 mM in the serum-free medium for 90 min. Following exposure to oxidative stress, these cells were washed twice with ice-cold PBS and lysed in sample buffer [50 mM Tris-HCl (pH 6.8), 10% glycerol, 4% SDS and 0.01% bromophenol blue]. For reduction of disulfide links, 50 mM DTT was added to the sample prior to electrophoresis. The samples were separated on 15% Tricine SDS-PAGE gels.

Plasmid transfection and pull down experiment

MKN-45 cells were cultured in a 60-mm dish and pME18S-FLAG-PP5 plasmid (2 μg) was transfected using FuGENE HD transfection reagent according to the manufacturer’s instructions (Roche Applied Science, Indianapolis, IN, USA). After 48 h, cells were treated with or without 2 mM H2O2 and 0.5 μM ionomycin for 90 min. Cells were washed once with PBS and lysed in a buffer consisting of 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5% Triton X-100, and 0.5% Nonidet P-40 with protease inhibitor mixture (Roche). The samples were sonicated and centrifuged at 16,600 × g for 10 min. Supernatants were incubated with 30 μl of anti-FLAG antibody-agarose in the presence of 1 mM CaCl2 for 2 h at room temperature. Following extensive washing, the beads were used either for the western blotting or in vitro phosphatase assay.

Surface plasmon resonance (SPR)

Protein binding analysis was performed using an SPR Biacore 2000 system (GE Healthcare Institute, Waukesha, WI, USA). N-ethyl-N′-(3-diethylaminopropyl) carbodiimide, N-hydroxysuccinimide and ethanolamine-HCl (GE Healthcare) were used for amine coupling of PP5 or S100A1 to the dextran surface of the CM5 chip. His-PP5 [2500 RU (pH 4.2)] or S100A1 [1400 RU (pH 4.5)] were immobilized in 10-mM ammonium acetate. For all the procedures, HBS-P buffer [20 mM HEPES (pH 7.4), 150 mM NaCl and 0.005% Tween-20] with 1 mM CaCl2 were used at a flow rate of 20 μl/min. Various concentrations of recombinant S100 proteins were injected. The ligand-coupled sensor chips were regenerated between protein injections with a brief (60 sec) wash with HBS-P buffer containing 2.5 mM ethyleneglycol-bis-(2-aminoethylether)-tetra acetic acid (EGTA) and 0.75% n-octyl-β-D-glucopyranoside. Response curves were prepared for fitting by subtraction of the signal generated simultaneously on the control flow cell. Biacore sensorgrams were analyzed using BIAevaluation 4.1 software (GE Healthcare).

Native PAGE, Tricine SDS-PAGE and western blotting

Native PAGE analysis was performed based on a previous study (25). Tricine SDS-PAGE gel electrophoresis was performed under reducing and non-reducing conditions. The gels were either stained with Coomassie Brilliant Blue (CBB) or used for western blotting. For western blot analysis, proteins were blotted onto nitrocellulose membranes and blocked with 5% skimmed milk in Tris-buffered saline with 0.05% Tween-20 (TTBS). The membranes were incubated with an anti-S100 antibody in the same buffer overnight. Membranes were washed with TTBS and incubated with an HRP-labeled second antibody for 2 h. To detect the FLAG-tagged PP5, the anti-FLAG-HRP antibody was used. The samples were washed and signals were detected using Immobilon Western Chemiluminescent HRP Substrate (Millipore, Billerica, MA, USA).

In vitro phosphatase assay

Phosphatase activity of PP5 was measured using a Ser/Thr Phosphatase Assay kit (Upstate Biotechnology, Lake Placid, NY, USA) in accordance with the manufacturer’s instructions. The phosphopeptide (KRpTIRR; 100 μM) was incubated with 250 ng of His-PP5 in a buffer consisting of 20 mM Tris-HCl (pH 7.5), 20 mM MgCl2, 0.01% Tween-20 with 1 mM CaCl2 or EGTA in a volume of 50 μl. Various amounts (0–10 μg) of S100 proteins were added and incubated for 10 min at 37°C. Following the addition of 100 μl of malachite green solution (0.034% malachite green, 10 mM ammonium molybdate, 1 M HCl, 3.4% ethanol and 0.01% Tween-20), the absorbance of samples at 630 nm was measured using a microplate reader. The amount of released phosphate was calculated using a phosphate standard curve prepared from a known amount of phosphate. To measure the PP5 activity bound to the FLAG-agarose beads, 10 μl of beads (in triplicate) were used and incubated in the presence of 1 mM CaCl2 for 1 h at 37°C. The samples were centrifuged and supernatants were used for the assay.

Statistical analysis

Statistical analysis was performed using the Student’s t-test and P<0.05 was considered to indicate a statistically significant difference. Data are expressed as the means ± standard deviation.

Results

Oxidation of S100A4 promotes oligomerization by intermolecular disulfide bridge formation and inhibits PP5 activation by S100A1

The preliminary experiments indicated that the effects of S100A4 on S100A1-stimulated PP5 activity varied from sample to sample (i.e., duration of storage of S100A4 preparation). It was suspected that the sample-to-sample variation depended on the oxidation level of S100A4 during storage. Recombinant S100A4 protein was purified from E. coli and the protein was immediately used as a freshly prepared sample. Air-oxidized S100A4 was prepared by maintaining the diluted protein (0.5 mg/ml) in a freezer at −30°C for three months in order to promote oxidation. Air-oxidized and freshly prepared samples were separated with Tricine SDS-PAGE gel under reducing (with DTT) or non-reducing (without DTT) conditions, followed by staining with CBB (Fig. 1A). With or without DTT treatment, the majority of proteins were observed as monomers and a small portion was observed as dimers in the freshly prepared S100A4 lanes. Without DTT, air-oxidation decreased the monomeric form and increased the dimeric form. In addition, smear bands were observed above the dimer band that could represent higher molecular weight (HMW) forms. Treatment with DTT decreased the dimeric and HMW forms, while the amount of monomer increased. These results indicate that oxidation of S100A4 promoted oligomerization by intermolecular disulfide bridge formation. Subsequently, the PP5 activation assay was performed (Fig. 1B). The basic activity of PP5 is kept extremely low (26). In the presence of Ca2+, S100A1 significantly activated PP5 (593.7±32.0 nmol/min/ng protein with 10 μg of S100A1), but no clear activation was observed in the presence of EGTA. When a fixed amount of S100A1 (2.5 μg) and increasing amounts of freshly prepared S100A4 were used, S100A4 showed no clear effects on S100A1 activated PP5 activity in the presence of Ca2+ (Fig. 1C). Freshly prepared S100A4 itself could not activate PP5, even in the presence of Ca2+. However, addition of air-oxidized S100A4 to the fixed amount of S100A1 dose-dependently inhibited activation of PP5 by S100A1 in the presence of Ca2+ (Fig. 1D). No activation was observed with the air-oxidized S100A4.

Figure 1

Oxidation of S100A4 and its effect on PP5 activation by S100A1. (A) Air-oxidized and freshly prepared S100A4 were separated on a 15% Tricine SDS-PAGE gel under reducing [dithiothreitol (DTT) (+)] or non-reducing [(DTT(−)] conditions, followed by staining with Coomassie Brilliant Blue (CBB). HMW, high molecular weight complex. Molecular weight markers are shown on the right (kDa). (B) PP5 activation assay. His-PP5 (250 ng) was mixed with 100 μM phosphopeptide and various amounts of S100A1 in the presence of 1 mM CaCl2 or EGTA, followed by incubation for 10 min at 37°C. Malachite green solution with 0.01% Tween-20 was added and absorbance at 630 nm was measured. The amount of released phosphate was determined using a standard curve calculated from a known amount of phosphate. Each point represents the mean ± standard deviation (SD) of triplicate determinations. Fixed amounts (2.5 μg) of S100A1 and various amounts of (C) freshly prepared S100A4 or (D) air-oxidized S100A4 were used for the PP5 activation assay in the presence of 1 mM CaCl2. Each point represents the mean ± SD of triplicate determinations.

Air-oxidized S100A4 inhibits the interaction between PP5 and S100A1

In order to understand the mechanism through which oxidized S100A4 inhibits PP5 activation by S100A1, SPR analysis was performed to measure the interaction between S100A4 or S100A1 and PP5 (Fig. 2). To determine whether a positive interaction existed between S100A1 and freshly prepared S100A4, individual binding experiments were first performed for saturating amounts of each protein (10 μM) using a PP5-coupled chip (Fig. 2A). There were larger amounts of freshly prepared S100A4 bound to PP5, as compared to S100A1 (~330 RU of S100A4 and 159 RU of S100A1 at 150 sec). In the second experiment, S100A1 was first injected over the PP5-coupled chip, and following association with S100A1, freshly prepared S100A4 was added using the COINJECT function of the Biacore instrument. Under these reaction conditions (Fig. 2B), the sum of the interactions appeared to be additive. When the order of addition was reversed (S100A1 and freshly prepared S100A4 were injected first, followed by S100A1), the binding events were found to be additive for PP5 (Fig. 2C). These results indicated that the proteins bind independently from one another, and that these two proteins may not physically interact. By contrast, air-oxidized S100A4 significantly lost its ability to bind PP5 (Fig. 2D) and notably, increased amounts of oxidized S100A4 inhibited the binding of S100A1 to PP5 in a dose-dependent manner (Fig. 2E). This result agreed with the inhibitory effect of the oxidized S100A4 on the PP5 activation by S100A1 (Fig. 1D). These results indicate that oxidized S100A4 prevented S100A1 from PP5 activation by forming complexes with S100A1, but not by competitively disturbing the interaction between PP5 and S100A1.

Figure 2

Interaction between PP5 and S100 proteins. Protein binding analysis was performed using a SPR Biacore 2000 system. N-ethyl-N′-(3-diethylaminopropyl) carbodiimide, N-hydroxysuccinimide, and ethanolamine-HCl (Biacore) were used for amine coupling of PP5 or S100A1 to the dextran surface of the CM5 chip. His-PP5 [2500 RU (pH 4.2)] or S100A1 [1400 RU (pH 4.5)] was immobilized in 10-mM ammonium acetate. Various concentrations of recombinant S100 proteins were injected. Response curves were prepared for fitting by subtraction of the signal generated simultaneously on the control flow cell. Biacore sensorgrams were analyzed using BIAevaluation 4.1 software. (A) Freshly prepared S100A1 or S100A4. (B) Freshly prepared S100A1 firstly, followed by injection of S100A1 and S100A4. (C) S100A1 and S100A4 were injected, followed by S100A1 alone. (D) Various concentrations of air-oxidized S100A4 were injected. (E) Fixed amount (5 μM) of S100A1 and various concentrations of air-oxidized S100A4 were injected.

Cu-oxidized S100A4 fails to interact with PP5 and inhibits interaction between PP5 and S100A1

The effects of oxidized S100A4 were further examined on PP5 activation by copper oxidation. Freshly prepared and Cu-oxidized S100A4 was separated with Tricine SDS-PAGE gel under reducing (with DTT) or non-reducing (without DTT) conditions and stained with CBB (Fig. 3A). Freshly prepared S100A4 formed a monomer and a small portion was dimeric, as shown in Fig. 1A. Without DTT, Cu oxidation significantly decreased the monomeric form and increased the dimeric and HMW forms. Treatment with DTT decreased the dimeric and HMW forms, while the amount of monomer increased. The PP5 activation assay was also performed. Cu-oxidized S100A4 was unable to activate PP5, and addition of the Cu-oxidized S100A4 to a fixed amount of S100A1 (2.5 μg/tube) dose-dependently inhibited activation of PP5 by S100A1 in the presence of Ca2+ (Fig. 3B). A similar inhibitory effect was observed with air-oxidized S100A4 in Fig. 1D. Using the PP5 immobilized chip, Cu-oxidized S100A4 failed to bind PP5 (Fig. 3D), whereas the dose-dependent binding of freshly prepared S100A4 was observed by SPR (Fig. 3C). When S100A1 was immobilized on the chip, freshly prepared S100A4 bound only slightly to the S100A1-coupled chip (Fig. 3E). Notably, the oxidation of S100A4 clearly increased its affinity for S100A1 (Fig. 3F). The binding of Cu-oxidized S100A4 to S100A1 increased ~3-fold (90 RU at 150 sec) compared to that of freshly prepared S100A4 (33 RU at 150 sec).

Figure 3

Effects of Cu-oxidized S100A4 on the interaction with PP5 or S100A1 and PP5 activation. (A) Freshly prepared and Cu-oxidized S100A4 were separated on 15% Tricine SDS-PAGE gels under reducing [dithiothreitol (DTT) (+)] or non-reducing [(DTT(−)] conditions, and were stained with Coomassie Brilliant Blue (CBB). HMW, high molecular weight complex. Molecular weight markers are shown on the right (kDa). (B) Various amounts of Cu-oxidized S100A4 with or without fixed amount of S100A1 (2.5 μg) were used for the PP5 activation assay in the presence of 1 mM CaCl2. Each point represents the mean ± standard deviation (SD) of triplicate determinations. (C) His-PP5 was immobilized on the sensor chip and various amounts of freshly prepared S100A4 were applied. Binding was measured by surface plasmon resonance (SPR). (D) The binding of Cu-oxidized S100A4 onto the PP5-immobilized chip was measured. (E) S100A1 was immobilized on the sensor chip and various amounts of freshly prepared S100A4 were applied. Binding was measured by SPR analysis. (F) Binding of Cu-oxidized S100A4 to the S100A1 immobilized on the chip was measured.

Native PAGE analysis of S100 proteins and PP5 interaction

In order to confirm SPR experiments, a non-denaturing gel shift assay previously used for calmodulin (CaM) binding proteins was employed (27,28). In the presence of Ca2+, S100A1 was mainly observed as a dimer and a faint multimer band (Fig. 4A and B). As has been previously reported (29), freshly prepared S100A4 was detected near the origin of the gel as a broad band. Cu-oxidized S100A4 formed a broad band, but the electrophoretic mobility was different from that of freshly prepared S100A4. PP5 was unable to migrate into gels, and was observed as a sharp band on the top of the separating gel. Possible binding between the S100 proteins and PP5 was subsequently tested, in which mixtures of the two were run on non-denaturing polyacrylamide gels. Mixtures of S100A1 and PP5 formed new multiple bands (indicated by closed arrow heads), thus indicating the interaction between these proteins. By contrast, addition of freshly prepared S100A4 and Cu-oxidized S100A4 did not alter PP5 mobility in the presence of Ca2+.

Figure 4

Native PAGE analysis of S100-PP5 interaction and the effect of H2O2 on S100A4 in MKN-45 cells. (A) Approximately 10 μg each of S100A1, S100A4 or Cu-oxidized S100A4 was separated on the gel (left three lanes). Same samples were incubated with PP5 and separated on the same gel (right three lanes). Gels were stained with Coomassie Brilliant Blue (CBB). Multiple bands formed by mixture of S100A1 and PP5 are indicated by closed arrow heads. (B) Approximately 10 μg each of freshly prepared S100A1, S100A4, Cu-oxidized S100A4, S100A1 + S100A4 or S100A1 + Cu-oxidized S100A4 were applied to the gels. Gels were stained with CBB. Electrophoretic mobility shifts of S100A1 by Cu-oxidized S100A4 are indicated (open arrowhead). Multiple bands formed by mixture of S100A1 and PP5 are indicated by closed arrow heads. (C) Approximately 5.5×105 cells were plated on a 10-cm dish and cultured for 3 days in standard medium. Medium was aspirated and washed with PBS and cells were exposed to the indicated concentrations of H2O2 ranging from 0 to 2 mM in the serum-free medium for 90 min. Proteins were extracted and separated on 15% Tricine SDS-PAGE under reducing [dithiothreitol (DTT) (+)] or non-reducing [(DTT(−)]conditions. Western blot analysis was performed using an anti-S100A4 antibody. HMW, high molecular weight complexes. The band migrating with an apparent MW of 60 kDa is a non-specific horseradish peroxidase (HRP)-labeled secondary antibody-reactive band. Molecular weight markers are shown on the right (kDa).

Subsequently, the interaction between S100A4 and S100A1 was examined (Fig. 4B). Cu-oxidized S100A4 caused a notable shift in the electrophoretic mobility of S100A1 (indicated open arrowheads), whereas freshly prepared S100A4 did not. Taken together, these results indicate that Cu-oxidized S100A4, but not freshly prepared S100A4, directly interact with S100A1.

Oxidative stress promotes oligomerization of S100A4 by intermolecular disulfide bridge formation in MKN-45 cells

A previous study indicated that treatment with H2O2 strongly promoted intermolecular disulfide cross-linking of naturally expressed S100A2 in human keratinocytes or HaCaT cells (30). According to the reported procedure (21), whether oxidative stress promotes the intermolecular disulfide cross-linking of S100A4 in the intact cells was examined. MKN-45 gastric adenocarcinoma cells were used as this cell line is often used for the oxidative stress study and the expression of S100A4 was confirmed (31). Following treatment with various concentrations of H2O2, cells were lysed in SDS-PAGE sample buffer without any reducing agents. The samples were treated with or without DTT and separated on Tricine SDS-PAGE gels. S100A4 was detected by western blotting with an anti-S100A4 antibody (Fig. 4C). H2O2 treatment increased the formation of dimeric S100A4 and HMW complexes in a dose-dependent manner (Fig. 4C, left panel). Addition of DTT clearly reduced the formation of these forms (Fig. 4C, right panel), indicating that the intermolecular disulfide cross-linking of S100A4 occurs in intact cells.

Oxidized S100A4 inhibits the activation of PP5 by S100A1 in MKN-45 cells

Subsequently, the effect of H2O2 on S100A1-PP5 interaction and PP5 activation was examined. FLAG-tagged PP5 was expressed in the MKN-45 cells and cells were treated with or without 2 mM H2O2 and 0.5 μM ionomycin for 90 min. The result of the pull down experiment showed that H2O2 treatment decreased the S100A1 binding to PP5 (Fig. 5A). In addition, the PP5 activity was inhibited to 61.6±12.1% of the control (P<0.05; Fig. 5B). Together with the results of Figs. 3 and 4C, this data indicated that oxidized S100A4 prevented the binding of S100A1 to PP5, resulting in the inhibition of PP5 activation.

Figure 5

Effect of oxidative stress on S100A1-PP5 interaction and PP5 activation in MKN-45 cells. (A) MKN-45 cells were transfected with pME18S-FLAG-PP5 plasmid. The cells were treated with or without 2 mM H2O2 and 0.5 μM ionomycin for 90 min. The pull down experiment was performed using 400 μg of total protein and anti-FLAG agarose. Following intensive washes, the samples were separated with Tricine SDS-PAGE gels and western blotting was carried out using indicated antibodies. Approximately 20 μg of protein was used as an input. (B) Phosphatase activity of FLAG-agarose bound PP5 was measured and relative phosphatase activity was calculated. Data are expressed as the mean ± standard deviation (SD) (n=3).

Discussion

S100A4 exerts its functions mainly through interaction with other proteins. Similar to other S100 proteins, a number of target proteins for S100A4 have been identified, including actin, non-muscle myosin IIA and IIB, tropomyosin, p53, liprin β1, methionine aminopeptidase 2, CCN3, p37, and septin 2, 6 and 7 (3–6,32–34). However, the functional correlations between S100A4-target interactions have not been widely described. In the extracellular space, S100A4 has been reported to interact with the receptor for advanced glycation end products (RAGE) and heparan sulfate proteoglycans (35,36). In general, the biological activity of extracellular S100A4 is associated with multimeric forms of the protein. In the intracellular space, S100A4 binds to the targets in a Ca2+-dependent manner and regulates cellular functions. An increase of intracellular Ca2+ concentration promotes the non-covalent dimerization of S100A4 (8). As well as homodimer formation, two-hybrid screening detected the S100A4-S100A1 heterodimer (9,10), and the interaction was detected in HeLa cells by fluorescence resonance energy transfer (10). In addition, oxidative modifications of S100 proteins induced their conformational changes and altered the functions. Several S100 proteins, such as S100A2, S100A3 or S100A4, have highly reactive cysteine residues at the surface that oxidize readily and form disulfide bonds (37). The present study demonstrated that air- and Cu-oxidation of S100A4 promoted the formation of covalently (disulfide)-linked dimer or HMW complexes (Fig. 1A). Of note, oxidation of S100A4 markedly decreased the affinity to PP5 (Figs. 2D and 3D), but increased its affinity to S100A1 (Fig. 3F). This could result from oligomerization of S100A4 by intermolecular disulfide bridge formation, not from oligomerization under normal reducing conditions. Under normal circumstances, the TPR domain covers the catalytic domain of the enzyme and maintains a low activity (26). Although S100A1 and S100A4 are able to bind to the TPR domain of PP5 in a Ca2+-dependent manner, only S100A1 uncovers the catalytic domain, resulting in enzyme activation. SPR analysis in Fig. 2B and C supports the idea that S100A1 and S100A4 bind to a different region in PP5. When ROS are generated and the redox signaling pathway is activated, oxidized S100A4 binds to S100A1 and prevents PP5 activation. Although the detailed structure of the oxidized S100A4 is unknown, dimerization or oligomerization of S100A4 by intermolecular disulfide bridge formation concealed the interaction site with the TPR domain of PP5 and exposed the S100A1-interacting domain. Oxidation of S100A4 and inhibition of PP5 activation by S100A1 was observed in MKN-45 gastric adenocarcinoma cells following H2O2 treatment (Figs. 4C and 5B), thus, indicating that S100A4 could be oxidized under the strong oxidative stress conditions and may modulate signaling pathways inside the cells. A few studies have described the function of oxidized S100A4 in the extracellular space; the oligomeric forms of S100A4 strongly induced differentiation of cultured hippocampal neurons (38), and copper-mediated cross-linking of S100A4 increased NF-κB activation and TNF-α secretion in human A375 and in RAGE-transfected melanoma cells (39). By contrast, the role of oxidized S100A4 in the intracellular space is limited. The present results indicate that S100A4 is able to modulate the activity of PP5 on oxidative stress. PP5 is a negative regulator of ASK1, and PP5 activation by S100A1 and de-activation by oxidized S100A4 modulated apoptosis by regulating ASK1 activity under oxidative stress conditions. As gastric epithelium is exposed to ROS generated by food, cigarette smoke and inflammation by Helicobacter pylori infection that activates ASK1 under oxidative conditions, modulation of apoptosis could be important for the maintenance of mucosal homeostasis. Further study is required to help to understand the role of S100 proteins on gastric mucosa maintenance or tumor progression under oxidative stress conditions.

Acknowledgements

The present study was supported by the Kagawa University Characteristic Prior Research Fund 2011 (Kagawa, Japan). The authors would like to thank Keiko Tsurumi (a laboratory technician; Kagawa University) for technical assistance.

Abbreviations:

ASK1

apoptosis stimulating kinase 1

CaM

calmodulin

CBB

Coomassie brilliant blue

DTT

dithiothreitol

H2O2

hydrogen peroxide

HMW

higher molecular weight

His

6xHistidine

HRP

horseradish peroxidase

NF-κB

nuclear factor-κB

PBS

phosphate-buffered saline

PP5

protein phosphatase 5

PPP

phosphoprotein phosphatase

ROS

reactive oxygen species

SPR

surface plasmon resonance

TNF-α

tumor necrosis factor α

TPR

tetratricopeptide repeat

Tricine

N-[2-hydroxy-1,1-bis (hydroxymethyl) ethyl] glycine

TTBS

Tris-buffered saline with 0.05% Tween-20

References

1 

Schäfer BW and Heizmann CW: The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci. 21:134–140. 1996.PubMed/NCBI

2 

Santamaria-Kisiel L, Rintala-Dempsey AC and Shaw GS: Calcium-dependent and -independent interactions of the S100 protein family. Biochem J. 396:201–214. 2006. View Article : Google Scholar : PubMed/NCBI

3 

Kriajevska M, Fischer-Larsen M, Moertz E, et al: Liprin beta 1, a member of the family of LAR transmembrane tyrosine phosphatase-interacting proteins, is a new target for the metastasis-associated protein S100A4 (Mts1). J Biol Chem. 277:5229–5235. 2002. View Article : Google Scholar : PubMed/NCBI

4 

Endo H, Takenaga K, Kanno T, Satoh H and Mori S: Methionine aminopeptidase 2 is a new target for the metastasis-associated protein, S100A4. J Biol Chem. 277:26396–26402. 2002. View Article : Google Scholar : PubMed/NCBI

5 

Garrett SC, Varney KM, Weber DJ and Bresnick AR: S100A4, a mediator of metastasis. J Biol Chem. 281:677–680. 2006. View Article : Google Scholar : PubMed/NCBI

6 

Kiss B, Duelli A, Radnai L, Kékesi KA, Katona G and Nyitray L: Crystal structure of the S100A4-nonmuscle myosin IIA tail fragment complex reveals an asymmetric target binding mechanism. Proc Natl Acad Sci USA. 109:6048–6053. 2012. View Article : Google Scholar : PubMed/NCBI

7 

Tarabykina S, Kriajevska M, Scott DJ, et al: Heterocomplex formation between metastasis-related protein S100A4 (Mts1) and S100A1 as revealed by the yeast two-hybrid system. FEBS Lett. 475:187–191. 2000. View Article : Google Scholar : PubMed/NCBI

8 

Tarabykina S, Scott DJ, Herzyk P, et al: The dimerization interface of the metastasis-associated protein S100A4 (Mts1): in vivo and in vitro studies. J Biol Chem. 276:24212–24222. 2001. View Article : Google Scholar : PubMed/NCBI

9 

Wang G, Rudland PS, White MR and Barraclough R: Interaction in vivo and in vitro of the metastasis-inducing S100 protein, S100A4 (p9Ka) with S100A1. J Biol Chem. 275:11141–11146. 2000. View Article : Google Scholar : PubMed/NCBI

10 

Wang G, Zhang S, Fernig DG, Martin-Fernandez M, Rudland PS and Barraclough R: Mutually antagonistic actions of S100A4 and S100A1 on normal and metastatic phenotypes. Oncogene. 24:1445–1454. 2005. View Article : Google Scholar : PubMed/NCBI

11 

Deloulme JC, Gentil BJ and Baudier J: Monitoring of S100 homodimerization and heterodimeric interactions by the yeast two-hybrid system. Microsc Res Tech. 60:560–568. 2003. View Article : Google Scholar : PubMed/NCBI

12 

Pröpper C, Huang X, Roth J, Sorg C and Nacken W: Analysis of the MRP8-MRP14 protein-protein interaction by the two-hybrid system suggests a prominent role of the C-terminal domain of S100 proteins in dimer formation. J Biol Chem. 274:183–188. 1999.PubMed/NCBI

13 

Wang G, Zhang S, Fernig DG, et al: Heterodimeric interaction and interfaces of S100A1 and S100P. Biochem J. 382:375–383. 2004. View Article : Google Scholar : PubMed/NCBI

14 

Yamaguchi F, Umeda Y, Shimamoto S, et al: S100 proteins modulate protein phosphatase 5 function: a link between CA2+ signal transduction and protein dephosphorylation. J Biol Chem. 287:13787–13798. 2012. View Article : Google Scholar : PubMed/NCBI

15 

Hinds TD Jr and Sánchez ER: Protein phosphatase 5. Int J Biochem Cell Biol. 40:2358–2362. 2008. View Article : Google Scholar

16 

Becker W, Kentrup H, Klumpp S, Schultz JE and Joost HG: Molecular cloning of a protein serine/threonine phosphatase containing a putative regulatory tetratricopeptide repeat domain. J Biol Chem. 269:22586–22592. 1994.

17 

Chen MX, McPartlin AE, Brown L, Chen YH, Barker HM and Cohen PT: A novel human protein serine/threonine phosphatase, which possesses four tetratricopeptide repeat motifs and localizes to the nucleus. EMBO J. 13:4278–4290. 1994.PubMed/NCBI

18 

D’Andrea LD and Regan L: TPR proteins: the versatile helix. Trends Biochem Sci. 28:655–662. 2003.PubMed/NCBI

19 

Zeytuni N and Zarivach R: Structural and functional discussion of the tetra-trico-peptide repeat, a protein interaction module. Structure. 20:397–405. 2012. View Article : Google Scholar : PubMed/NCBI

20 

Morita K, Saitoh M, Tobiume K, et al: Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. EMBO J. 20:6028–6036. 2001. View Article : Google Scholar : PubMed/NCBI

21 

Gencer S and Irmak Yazicioğlu MB: Differential response of gastric carcinoma MKN-45 and 23132/87 cells to H2O2 exposure. Turk J Gastroenterol. 22:145–151. 2011.PubMed/NCBI

22 

Okada M, Hatakeyama T, Itoh H, Tokuta N, Tokumitsu H and Kobayashi R: S100A1 is a novel molecular chaperone and a member of the Hsp70/Hsp90 multichaperone complex. J Biol Chem. 279:4221–4233. 2004. View Article : Google Scholar : PubMed/NCBI

23 

Yamashita K, Oyama Y, Shishibori T, Matsushita O, Okabe A and Kobayashi R: Purification of bovine S100A12 from recombinant Escherichia coli. Protein Expr Purif. 16:47–52. 1999. View Article : Google Scholar : PubMed/NCBI

24 

Matsui Lee IS, Suzuki M, Hayashi N, et al: Copper-dependent formation of disulfide-linked dimer of S100B protein. Arch Biochem Biophys. 374:137–141. 2000.PubMed/NCBI

25 

Okada M, Tokumitsu H, Kubota Y and Kobayashi R: Interaction of S100 proteins with the antiallergic drugs, olopatadine, amlexanox, and cromolyn: identification of putative drug binding sites on S100A1 protein. Biochem Biophys Res Commun. 292:1023–1030. 2002. View Article : Google Scholar : PubMed/NCBI

26 

Chinkers M: Protein phosphatase 5 in signal transduction. Trends Endocrinol Metab. 12:28–32. 2001. View Article : Google Scholar : PubMed/NCBI

27 

Zühlke RD, Pitt GS, Deisseroth K, Tsien RW and Reuter H: Calmodulin supports both inactivation and facilitation of L-type calcium channels. Nature. 399:159–162. 1999.PubMed/NCBI

28 

Takata M, Shimamoto S, Yamaguchi F, Tokuda M, Tokumitsu H and Kobayashi R: Regulation of nuclear localization signal-importin alpha interaction by Ca2+/S100A6. FEBS Lett. 584:4517–4523. 2010. View Article : Google Scholar : PubMed/NCBI

29 

Gibbs FE, Wilkinson MC, Rudland PS and Barraclough R: Interactions in vitro of p9Ka, the rat S-100-related, metastasis-inducing, calcium-binding protein. J Biol Chem. 269:18992–18999. 1994.PubMed/NCBI

30 

Zhang T, Woods TL and Elder JT: Differential responses of S100A2 to oxidative stress and increased intracellular calcium in normal, immortalized, and malignant human keratinocytes. J Invest Dermatol. 119:1196–1201. 2002. View Article : Google Scholar

31 

Yonemura Y, Endou Y, Kimura K, et al: Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin Cancer Res. 6:4234–4242. 2000.PubMed/NCBI

32 

Watanabe Y, Usada N, Minami H, et al: Calvasculin, as a factor affecting the microfilament assemblies in rat fibroblasts transfected by src gene. FEBS Lett. 324:51–55. 1993. View Article : Google Scholar : PubMed/NCBI

33 

Takenaga K, Nakamura Y, Sakiyama S, Hasegawa Y, Sato K and Endo H: Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin. J Cell Biol. 124:757–768. 1994. View Article : Google Scholar : PubMed/NCBI

34 

Li CL, Martinez V, He B, Lombet A and Perbal B: A role for CCN3 (NOV) in calcium signalling. Mol Pathol. 55:250–261. 2002. View Article : Google Scholar : PubMed/NCBI

35 

Yammani RR, Carlson CS, Bresnick AR and Loeser RF: Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: Role of the receptor for advanced glycation end products. Arthritis Rheum. 54:2901–2911. 2006. View Article : Google Scholar : PubMed/NCBI

36 

Kiryushko D, Novitskaya V, Soroka V, et al: Molecular mechanisms of Ca2+ signaling in neurons induced by the S100A4 protein. Mol Cell Biol. 26:3625–3638. 2006.

37 

Fritz G: X-ray structural analysis of S100 proteins. Methods Mol Biol. 963:87–97. 2013. View Article : Google Scholar : PubMed/NCBI

38 

Novitskaya V, Grigorian M, Kriajevska M, et al: Oligomeric forms of the metastasis-related Mts1 (S100A4) protein stimulate neuronal differentiation in cultures of rat hippocampal neurons. J Biol Chem. 275:41278–41286. 2000. View Article : Google Scholar : PubMed/NCBI

39 

Haase-Kohn C, Wolf S, Lenk J and Pietzsch J: Copper-mediated cross-linking of S100A4, but not of S100A2, results in proinflammatory effects in melanoma cells. Biochem Biophys Res Commun. 413:494–498. 2011. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Tsuchiya M, Yamaguchi F, Shimamoto S, Fujimoto T, Tokumitsu H, Tokuda M and Kobayashi R: Oxidized S100A4 inhibits the activation of protein phosphatase 5 through S100A1 in MKN‑45 gastric carcinoma cells. Int J Mol Med 34: 1713-1719, 2014.
APA
Tsuchiya, M., Yamaguchi, F., Shimamoto, S., Fujimoto, T., Tokumitsu, H., Tokuda, M., & Kobayashi, R. (2014). Oxidized S100A4 inhibits the activation of protein phosphatase 5 through S100A1 in MKN‑45 gastric carcinoma cells. International Journal of Molecular Medicine, 34, 1713-1719. https://doi.org/10.3892/ijmm.2014.1947
MLA
Tsuchiya, M., Yamaguchi, F., Shimamoto, S., Fujimoto, T., Tokumitsu, H., Tokuda, M., Kobayashi, R."Oxidized S100A4 inhibits the activation of protein phosphatase 5 through S100A1 in MKN‑45 gastric carcinoma cells". International Journal of Molecular Medicine 34.6 (2014): 1713-1719.
Chicago
Tsuchiya, M., Yamaguchi, F., Shimamoto, S., Fujimoto, T., Tokumitsu, H., Tokuda, M., Kobayashi, R."Oxidized S100A4 inhibits the activation of protein phosphatase 5 through S100A1 in MKN‑45 gastric carcinoma cells". International Journal of Molecular Medicine 34, no. 6 (2014): 1713-1719. https://doi.org/10.3892/ijmm.2014.1947
Copy and paste a formatted citation
x
Spandidos Publications style
Tsuchiya M, Yamaguchi F, Shimamoto S, Fujimoto T, Tokumitsu H, Tokuda M and Kobayashi R: Oxidized S100A4 inhibits the activation of protein phosphatase 5 through S100A1 in MKN‑45 gastric carcinoma cells. Int J Mol Med 34: 1713-1719, 2014.
APA
Tsuchiya, M., Yamaguchi, F., Shimamoto, S., Fujimoto, T., Tokumitsu, H., Tokuda, M., & Kobayashi, R. (2014). Oxidized S100A4 inhibits the activation of protein phosphatase 5 through S100A1 in MKN‑45 gastric carcinoma cells. International Journal of Molecular Medicine, 34, 1713-1719. https://doi.org/10.3892/ijmm.2014.1947
MLA
Tsuchiya, M., Yamaguchi, F., Shimamoto, S., Fujimoto, T., Tokumitsu, H., Tokuda, M., Kobayashi, R."Oxidized S100A4 inhibits the activation of protein phosphatase 5 through S100A1 in MKN‑45 gastric carcinoma cells". International Journal of Molecular Medicine 34.6 (2014): 1713-1719.
Chicago
Tsuchiya, M., Yamaguchi, F., Shimamoto, S., Fujimoto, T., Tokumitsu, H., Tokuda, M., Kobayashi, R."Oxidized S100A4 inhibits the activation of protein phosphatase 5 through S100A1 in MKN‑45 gastric carcinoma cells". International Journal of Molecular Medicine 34, no. 6 (2014): 1713-1719. https://doi.org/10.3892/ijmm.2014.1947
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team